Autopsy report · NCT00928811

Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant

“Investigator left University 04/2010”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 11 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

Drexel University College of Medicine

Sponsor type

University, hospital or other

Conditions

End Stage Renal Disease

Interventions

basiliximab; basiliximab

Participants

5

Sites

1

Countries

United States

Trials that died the same way

• Brain Function in Depression and Insulin Resistance
  “Principal Investigator Left University” (87% match in meaning)
• Intralesional Tetracycline Injection in the Treatment of Chalazia
  “Investigator left the institution” (85% match in meaning)
• Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period
  “Investigator left institution” (85% match in meaning)
• Use of Cast Iron Pots to Improve Maternal Anemia
  “Original investigator has left the institution.” (80% match in meaning)
• Heat-not-burn Tobacco Product to Aid in Switching From Combustible to Noncombustible Nicotine (IQOS)
  “Investigator left institution and did not retain the study” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.